We only have this paper's title and publication details.
Read it at the sourceOligobenzamide inhibitors of the p53-hDM2 protein-protein interaction are described.
No takes yet. Share an insight, caveat, or question.
Plante et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: